Mae ein Cronfa Triniaethau Newydd, a gyflwynwyd yn 2017, wedi cyflymu mynediad at driniaethau newydd ac arloesol ar gyfer llawer o glefydau prin, gan gynnwys ffeibrosis systig, clefyd Fabry, clefyd Gaucher, a chlefyd Batten.
Our New Treatment Fund, which was introduced in 2017, has sped up access to new and innovative treatments for many rare diseases, including cystic fibrosis, Fabry disease, Gaucher disease and Batten disease.